Fourth-quarter gross margin was 75%, up 45 basis points year over year, driven primarily by favorable product mix. AtriCure reported fourth-quarter net income of $1.8 million versus a$15.6 million net loss a year earlier, and adjusted EBITDA of $19.9 million versus$12.7 million in 2024. EPS was $0.04 and adjusted EPS was$0.06, compared with a loss per share of $0.33 and adjusted loss per share of$0.08 in the prior-year quarter.In the fourth quarter, worldwide revenue was $140.5 million, increasing 13.1% ...